2 articles for “rivaroxaban”

Set a search alert

Research ArticleOpen accessEvery word in the titleRivaroxaban and its Effect on International Normalised Ratio-A Prospective Study of 28 Hip and Knee Arthroplasty PatientsV. Eranki, A. Pillai, G. Morrison, Cheng Hong YeoProblem statement: Rivaroxaban is an orally active, competitively reversible antagonist of activated factor Xa. The purpose of this study is to comment on Riveroxaban’s effect on INR. Approach: At the Queen Elizabeth Hospital, all patients undergoing elective anthroplasty were anticoagulated with 10mg of Rivaroxaban. All patients had INR measurements for 3 days post operatively. Further 16 patients had weekly INR … …Current Research in Medicine, Vol. 3, Issue 2 · 12 Jul 2012 · 21,044 accessesView PDF Cite

Research ArticleOpen accessIn the abstractStroke Prevention in Atrial Fibrillation: Pharmacologic UpdateWajeeha Saeed, J. W. Kusick, M. R. Sardar et al.For nearly half a century, the therapeutic options for the risk reduction of stroke in atrial fibrillation have been stagnant with vitamin K antagonists, such as warfarin, being the primary therapy. Although antiplatelet agents have been investigated over this time, they were never shown to reduce the risk of stroke at the level warfarin has. Considering the limited therapeutic options, … …Current Research in Medicine, Vol. 4, Issue 2 · 24 Jun 2013 · 6,762 accessesView PDF Cite